Table 2 List of GC-MS identified compounds found in more than 70% of the totality of the samples.

From: Volatile compounds emission from teratogenic human pluripotent stem cells observed during their differentiation in vivo

#

Name

p-value hiPSCSs vs. others at day 28

Previously Found in:

1

Heptane. 2.4-dimethyl-

0.06

Pseudomonas Aeruginosa21

H. Pylori22

Lung cancer cells23

2

Octane, 4-methyl

0.04

Breath of colorectal cancer24

Breath of lung cancer25

3*

Decane

0.005

Breath of liver cancer26

Pseudomonas Aeruginosa27

4*

Octane, 4,4-dimethyl-

0.0003

 

5*

Heptane. 2.5.5-trimethyl- ′

0.002

Skin of melanoma28

6*

Octane, 2,4,6-trimethyl-

0.0002

 

7*

Nonane, 2,6-dimethyl-

0.0003

 

8*

Undecane

0.00004

Breath of lung cancer29

Breath of neck and head cancer30

9*

Octane, 5-ethyl-2-methyl-

0.00007

 

10*

Nonanal

0.0008

Plasmodium Falciparum31

Breath of lung cancer32

Breath of ovarian cancer33

Human skin34

11*

Nonane, 4,5-dimethyl-

0.0003

Oral cancer35

12*

Undecane, 2,9-dimethyl-

<10−5

 

13*

Decanal

<10−5

Breath of ovarian cancer33

Human skin34

14

Undecane, 3,6-dimethyl-

0.06

 

15

3-Ethyl-3-methylheptane ′

0.7

 

16

Decane, 2,3,8-trimethyl-

0.05

Colon cancer cells culture36

17*

Dodecane. 4.6-dimethyl-′

0.00005

Plasmodium Falciparum31

18

Decane, 2,3,5,8-tetramethyl-

0.1

 

19*

2,4-Dimethyldodecane

0.0006

 

20

Tetradecane

0.3

Plasmodium Falciparum31

Human skin32

21

Decane, 3-ethyl-3-methyl

0.2

 

22

Phenol.3.5-bis(1.1-dimethylethyl)- ′

0.6

 
  1. For each compound the p-values between the groups of hiPSCSs injected mice and the others calculated at the 28th day are shown. The compounds with p < 0.01 are marked with a star. In the last column the cases where the VOCs were previously found are indicated.